Domino drug action
Nature Chemical Biology
2008년8월25일
The antibiotic trimethoprim, used primarily for the treatment of urinary tract infections, works by an unexpected ‘domino effect’ in which two enzymes in a pathway are both inhibited by a single drug, according to a paper online this week in Nature Chemical Biology. The work reveals new insights into the mechanism of a clinically used drug and highlights the potential of looking at metabolic pathways to understand drug action.
Trimethoprim is known to inhibit a bacterial enzyme called dihydrofolate reductase (DHFR). By using a method for simultaneously measuring all of the folate-related chemicals in a bacterial cell, Joshua Rabinowitz and colleagues found that trimethoprim was blocking not just the activity of DHFR, but also another enzyme in folate metabolism. The second enzyme was not directly inhibited by trimethoprim. Instead, inhibiting DHFR caused accumulation of the substrate, dihydrofolate, which was an inhibitor of the second enzyme. Therefore, trimethoprim created a cascade of enzyme inhibition.
doi: 10.1038/nchembio.108
리서치 하이라이트
-
2월18일
Nature Energy Focus issue: How extreme weather events disrupt energy systemsNature Energy
-
1월28일
Materials science: Increased nuclear waste storage corrosion at material interfacesNature Materials
-
1월9일
Ecology: Reassessing impacts of ocean acidification on fish behaviourNature
-
12월20일
Marine biology: Acidified oceans may corrode shark scalesScientific Reports
-
12월19일
Anthropology: The final stand of Homo erectusNature
-
12월17일
Energy: Health and financial impacts of time-of-use energy rates raise equity concernsNature Energy
